Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases

M. Gasperi, A. E. Castellano

Research output: Contribution to journalArticle

Abstract

Neurodegenerative diseases (ND) are a group of heterogeneous disorders characterized by unknown etiology, subtle onset, and progressive involvement of neuronal systems leading to degeneration and dysfunction. They represent a challenge for basic science and clinical medicine because of increasing prevalence, social cost, complex biochemistry and pathology, and lack of mechanism-based treatments. Endocrine modifications may accompany the progression of ND, due to the intimate connections between central nervous and endocrine systems. Reported data on endocrine changes in different ND have often been non-conclusive or conflicting. GH/IGF-I axis is involved in the regulation of brain growth, development, and metabolism. Dysfunctions in GH/IGF-I axis in most of ND are therefore reviewed. Whether GH deficiency, when present, may act as a contributory factor in the pathogenesis of these diseases, or might represent a consequence of it is presently unknown. A thorough effort in investigating every possible involvement of GH/IGF-I axis is warranted, in the light of future possible therapeutic strategies.

Original languageEnglish
Pages (from-to)587-591
Number of pages5
JournalJournal of Endocrinological Investigation
Volume33
Issue number8
Publication statusPublished - Sep 2010

Fingerprint

Insulin-Like Growth Factor I
Neurodegenerative Diseases
Growth Hormone
Endocrine System
Clinical Medicine
Growth and Development
Biochemistry
Central Nervous System
Pathology
Costs and Cost Analysis
Brain
Therapeutics

Keywords

  • GH
  • IGF-I
  • Neurodegenerative diseases

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases. / Gasperi, M.; Castellano, A. E.

In: Journal of Endocrinological Investigation, Vol. 33, No. 8, 09.2010, p. 587-591.

Research output: Contribution to journalArticle

@article{506870f9b62e4f77b1db3c0384483063,
title = "Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases",
abstract = "Neurodegenerative diseases (ND) are a group of heterogeneous disorders characterized by unknown etiology, subtle onset, and progressive involvement of neuronal systems leading to degeneration and dysfunction. They represent a challenge for basic science and clinical medicine because of increasing prevalence, social cost, complex biochemistry and pathology, and lack of mechanism-based treatments. Endocrine modifications may accompany the progression of ND, due to the intimate connections between central nervous and endocrine systems. Reported data on endocrine changes in different ND have often been non-conclusive or conflicting. GH/IGF-I axis is involved in the regulation of brain growth, development, and metabolism. Dysfunctions in GH/IGF-I axis in most of ND are therefore reviewed. Whether GH deficiency, when present, may act as a contributory factor in the pathogenesis of these diseases, or might represent a consequence of it is presently unknown. A thorough effort in investigating every possible involvement of GH/IGF-I axis is warranted, in the light of future possible therapeutic strategies.",
keywords = "GH, IGF-I, Neurodegenerative diseases",
author = "M. Gasperi and Castellano, {A. E.}",
year = "2010",
month = "9",
language = "English",
volume = "33",
pages = "587--591",
journal = "Journal of Endocrinological Investigation",
issn = "0391-4097",
publisher = "Springer International Publishing",
number = "8",

}

TY - JOUR

T1 - Growth hormone/insulin-like growth factor I axis in neurodegenerative diseases

AU - Gasperi, M.

AU - Castellano, A. E.

PY - 2010/9

Y1 - 2010/9

N2 - Neurodegenerative diseases (ND) are a group of heterogeneous disorders characterized by unknown etiology, subtle onset, and progressive involvement of neuronal systems leading to degeneration and dysfunction. They represent a challenge for basic science and clinical medicine because of increasing prevalence, social cost, complex biochemistry and pathology, and lack of mechanism-based treatments. Endocrine modifications may accompany the progression of ND, due to the intimate connections between central nervous and endocrine systems. Reported data on endocrine changes in different ND have often been non-conclusive or conflicting. GH/IGF-I axis is involved in the regulation of brain growth, development, and metabolism. Dysfunctions in GH/IGF-I axis in most of ND are therefore reviewed. Whether GH deficiency, when present, may act as a contributory factor in the pathogenesis of these diseases, or might represent a consequence of it is presently unknown. A thorough effort in investigating every possible involvement of GH/IGF-I axis is warranted, in the light of future possible therapeutic strategies.

AB - Neurodegenerative diseases (ND) are a group of heterogeneous disorders characterized by unknown etiology, subtle onset, and progressive involvement of neuronal systems leading to degeneration and dysfunction. They represent a challenge for basic science and clinical medicine because of increasing prevalence, social cost, complex biochemistry and pathology, and lack of mechanism-based treatments. Endocrine modifications may accompany the progression of ND, due to the intimate connections between central nervous and endocrine systems. Reported data on endocrine changes in different ND have often been non-conclusive or conflicting. GH/IGF-I axis is involved in the regulation of brain growth, development, and metabolism. Dysfunctions in GH/IGF-I axis in most of ND are therefore reviewed. Whether GH deficiency, when present, may act as a contributory factor in the pathogenesis of these diseases, or might represent a consequence of it is presently unknown. A thorough effort in investigating every possible involvement of GH/IGF-I axis is warranted, in the light of future possible therapeutic strategies.

KW - GH

KW - IGF-I

KW - Neurodegenerative diseases

UR - http://www.scopus.com/inward/record.url?scp=78049377300&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78049377300&partnerID=8YFLogxK

M3 - Article

C2 - 20930497

AN - SCOPUS:78049377300

VL - 33

SP - 587

EP - 591

JO - Journal of Endocrinological Investigation

JF - Journal of Endocrinological Investigation

SN - 0391-4097

IS - 8

ER -